Pioglitazone decreases diabetes, stroke risks in patients with prediabetes, cerebrovascular disease

In insulin-resistant patients with a recent ischemic stroke or transient ischemic attack, pioglitazone was shown to reduce the risk for developing type 2 diabetes and major cardiovascular events, according to an analysis of the IRIS trial.

(Article by healio.com)

We will respect your inbox and privacy